إسرائيل - العبرية - Ministry of Health

kivema ltd. - כלל האוכלוסיה - תמיסות שטיפה והרטבה בתוך העין ומחוצה לה של עדשות מגע

إسرائيل - العبرية - Ministry of Health

kivema ltd - cromoglicic acid as sodium - טיפות עיניים - cromoglicic acid as sodium 20 mg/ml - cromoglicic acid

إسرائيل - العبرية - Ministry of Health

kivema ltd - azelastine hydrochloride - טיפות עיניים - azelastine hydrochloride 0.05 %w/v - azelastine

إسرائيل - العبرية - Ministry of Health

padagis israel agencies ltd, israel - glyceryl trinitrate - משחה - glyceryl trinitrate 0.4 % - glyceryl trinitrate - glyceryl trinitrate - for relief of pain associated with chronic anal fissure. in the clinical development of the drug a modest effect has shown on improvement in average daily pain intensity.

إسرائيل - العبرية - Ministry of Health

j-c health care ltd - risperidone 1 mg - film coated tablets - risperidone - risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperdal was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperdal is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperdal is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distractibility or

إسرائيل - العبرية - Ministry of Health

j-c health care ltd - risperidone - תמיסה - risperidone 1 mg / 1 ml - risperidone - risperidone - risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperdal is indicated for the treatment of mania in bipolar disorder. these episodes are char

إسرائيل - العبرية - Ministry of Health

dexcel pharma technologies ltd - risperidone - טבליה - risperidone 1 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

إسرائيل - العبرية - Ministry of Health

dexcel pharma technologies ltd - risperidone - קפליות - risperidone 2 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

إسرائيل - العبرية - Ministry of Health

dexcel pharma technologies ltd - risperidone - טבליה - risperidone 3 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

إسرائيل - العبرية - Ministry of Health

dexcel pharma technologies ltd - risperidone - קפליות - risperidone 4 mg - risperidone - risperidone - risperidex is indicated for the management of schizophrenia and the manifestations of psychotic disorders. the antipsychotic efficacy of risperdone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidex is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidex is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidex is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract